Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
Rising procedure volumes—particularly nasal and sinus procedures, and those in the office setting—as well as the ongoing adoption of innovative and premium-priced products, such as new products being launched in the sinus stent market, will allow the US ENT and bronchoscopy device markets to expand moderately through 2026.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for ENT and bronchoscopy devices in the US across a 10-year period.
Procedures performed in the office will rise dramatically over the forecast period.
How will the rise in office-based procedures impact procedure volumes in the hospital or ASC setting?
Is the rise in office-based procedures consistent across all procedure types?
The increasing use of flexible endoscopy will continue to positively impact both the ENT and bronchoscopy device markets.
To what extent does the demand for video flexiblescopes translate into market growth?
How will the adoption of video flexiblescopes impact fiber flexiblescope sales, if at all?
The continued launch of new drug-eluting sinus stents is a driver of growth in the ENT device market.
How quickly will the sinus stent market grow and what will market revenues reach by 2026?
How will other high-growth markets, such as the balloon sinus dilation market, perform over the forecast period?
Already a Client? Log in to access this report.
Durugshan Wijayakumar is an analyst within the Brand Tracking team at Decision Resources Group, with extensive knowledge of orthopedic biologics, trauma, laparoscopic, and dental implant device markets. Durugshan holds a Bachelor's Honors degree from the University of Toronto.